Phase 2 N=13 Safety and Efficacy of a Combination Product for the Prevention of Veisalgia
Veisalgia
Primary: Efficacy of Side Effect Prevention Using the Acute Hangover Scale — 6.7; 4.7; 7.8; 6.8 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=23 Vestibular Intervention Via Portable Electrical Stimulator (VIPES)
Balance Disorder
Primary: Change in Balance Performance — 0.52; 0.42; 0.51; 0.48 degrees per second
N/A N=241 Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial
Obesity
Primary: Percentage Change of Weight From Baseline — -2.46; -1.97 Percentage change from baseline